2020
DOI: 10.1177/1074248420919966
|View full text |Cite
|
Sign up to set email alerts
|

PKM2 Activator TEPP-46 Attenuates Thoracic Aortic Aneurysm and Dissection by Inhibiting NLRP3 Inflammasome-Mediated IL-1β Secretion

Abstract: Background: The development of thoracic aortic aneurysm and dissection (TAAD) is mediated by inflammasome activation, which exacerbates the secretion of pro-inflammatory cytokines, chemokines, matrix metalloproteinases (MMPs), and reactive oxygen species (ROS). The glycolytic enzyme pyruvate kinase M2 (PKM2) has shown a protective role against various disorders with an inflammatory basis, such as sepsis, tumorigenesis, and diabetic nephropathy. However, its potential role in TAAD has not been investigated so f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
25
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(25 citation statements)
references
References 61 publications
0
25
0
Order By: Relevance
“…found that PKM2 activator TEPP-46 attenuates β-aminopropionitrile fumarate (BAPN)-induced mouse model of thoracic aortic aneurysm and dissection (TAAD) by inhibiting NLRP3 inflammasome-mediated IL-1β secretion. This provides a new treatment strategy for TAAD ( 55 ). In this study, we have shown direct evidence of PKM2 tetramer-mediated macrophage endotoxin tolerance in primary macrophages (PMs and KCs), as well as in the RAW264.7 cell line.…”
Section: Discussionmentioning
confidence: 99%
“…found that PKM2 activator TEPP-46 attenuates β-aminopropionitrile fumarate (BAPN)-induced mouse model of thoracic aortic aneurysm and dissection (TAAD) by inhibiting NLRP3 inflammasome-mediated IL-1β secretion. This provides a new treatment strategy for TAAD ( 55 ). In this study, we have shown direct evidence of PKM2 tetramer-mediated macrophage endotoxin tolerance in primary macrophages (PMs and KCs), as well as in the RAW264.7 cell line.…”
Section: Discussionmentioning
confidence: 99%
“…2 So far, only a few studies have investigated its role using a BAPN induced dissecting model of TAA. 1,3,4 Interestingly, the administration of BAPN was associated with a local, but not systemic, increased expression of IL-1b in the aorta. 3 In another study, the use of enzyme pyruvate kinase M2 activator TEPP-46 demonstrated its efficacy to attenuate TAA formation by inhibiting pyrin domain containing protein 3 inflammasome, which was associated with a decrease in IL-1b expression in the thoracic aorta.…”
Section: Deciphering the Role Of Interleukin-1b In The Development Ofmentioning
confidence: 97%
“…These findings were further supported by Li et al demonstrating that co-treatment of human monocytic THP-1 cells with TEPP-46 and 2-deoxy-D-glucose reversed hyperglycemia-induced NLRP3 activation [ 185 ] ( Figure 2 ). Conversely, TEPP-46-mediated activation of PKM2 inhibited NLRP3 inflammasome-mediated IL-1β secretion in a β-aminopropionitrile fumarate (BAPN)-treated mouse model of thoracic aortic aneurysm and dissection (TAAD) [ 186 ]. These findings are in line with those of the O’Neill group, demonstrating that PKM2 activation in vivo using TEPP inhibits IL-1β production in an experimental model of Salmonella typhimurium infection [ 128 ].…”
Section: Emerging Areas Of Research Involving Pkm2mentioning
confidence: 99%